These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 35246773)

  • 1. Validation sentinel lymph node biopsy study in cN0 axilla using low-cost dual dye technique: potential solution for resource poor settings.
    Chavda J; Mishra A; Silodia A; Yadav SK; Sharma DB; Sharma D; Khandare M
    Breast Cancer Res Treat; 2022 May; 193(1):105-110. PubMed ID: 35246773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients with Positive Nodes Using Low-Cost Dual Dye Technique: Identifying Factors Associated with Adequate False Negative Rate Threshold.
    Yadav SK; Chavda J; Mishra A; Sharma D; Rawat SJ; Jain R
    Breast Care (Basel); 2024 Jun; 19(3):142-148. PubMed ID: 38894957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-cost Fluorescein as an Alternative to Radio-colloid for Sentinel Lymph Node Biopsy-a Prospective Validation Study in Early Breast Cancer.
    Valiveru RC; Agarwal G; Agrawal V; Gambhir S; Mayilvaganan S; Chand G; Mishra A; Agarwal A; Mishra SK
    World J Surg; 2020 Oct; 44(10):3417-3422. PubMed ID: 32504276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved false-negative rates using a novel patient selection flowchart in initially biopsy-proven node-positive breast cancer undergoing blue-dye alone guided sentinel lymph node biopsy after neoadjuvant chemotherapy.
    Chen M; Li S; Huang M; Guo J; Huang X; Guo W; Chen L; Lin Y; Jacobs L; Wang C; Fu F
    Breast Cancer Res Treat; 2022 Nov; 196(2):267-277. PubMed ID: 36100784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of blue dye alone for sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with initially node-positive breast cancer.
    Cavalcante FP; Zerwes FP; Souza ABA; Ziegelmann PK; Alcantara R; Cardoso A; Mattar A; Millen EC; Frasson AL
    Eur J Surg Oncol; 2024 Mar; 50(3):107967. PubMed ID: 38262300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparative Validation of Primary Surgical Versus Post-neo-adjuvant Chemotherapy Sentinel Lymph Node Biopsy for Stage III Breast Cancers.
    Agarwal G; Rajan S; Gambhir S; Lal P; Krishnani N; Kheruka S
    World J Surg; 2016 Jul; 40(7):1583-9. PubMed ID: 26324160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.
    Boughey JC; Suman VJ; Mittendorf EA; Ahrendt GM; Wilke LG; Taback B; Leitch AM; Kuerer HM; Bowling M; Flippo-Morton TS; Byrd DR; Ollila DW; Julian TB; McLaughlin SA; McCall L; Symmans WF; Le-Petross HT; Haffty BG; Buchholz TA; Nelson H; Hunt KK;
    JAMA; 2013 Oct; 310(14):1455-61. PubMed ID: 24101169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with initial nodal involvement due to breast cancer who have received neoadjuvant chemotherapy: Combined sentinel node-radioguided surgery of the pathological node.
    Fuertes Manuel J; Kohan S; Jordà Solé M; Mateu Hidalgo I; Miralles Curto M; Aguiló Sagristà O; Aguilar Alomá E; Peña González K; Lafuerza Torres A; Melé Olivé M; Repkova J; Montero Jaime MJ; Gumà Padró J
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(5):284-291. PubMed ID: 35597764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review and meta-analysis of diagnostic performance of fluorescein-guided sentinel lymph node biopsy in early breast cancer.
    Yadav SK; Bharath S; Sharma D; Srivastava A; Jha CK; Agarwal G; Khadka S; Singh M; Shekhar S; Goyal A
    Breast Cancer Res Treat; 2024 Jul; 206(1):19-30. PubMed ID: 38668856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axillary ultrasound after neoadjuvant therapy reduces the false-negative rate of sentinel lymph node biopsy in patients with cytologically node-positive breast cancer.
    Liu Y; Wang Y; Feng S; Xu Z; Yao M; Huang X; Li P; Wu L; Liu C; Chen X; Liang C; Liu Z
    Breast Cancer Res Treat; 2023 Feb; 197(3):515-523. PubMed ID: 36513955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer.
    Kida K; Ishikawa T; Yamada A; Shimizu D; Tanabe M; Sasaki T; Ichikawa Y; Endo I
    Eur J Surg Oncol; 2015 Apr; 41(4):566-70. PubMed ID: 25650249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved False-Negative Rates with Intraoperative Identification of Clipped Nodes in Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy.
    Cabıoğlu N; Karanlık H; Kangal D; Özkurt E; Öner G; Sezen F; Yılmaz R; Tükenmez M; Önder S; İğci A; Özmen V; Dinççağ A; Engin G; Müslümanoğlu M
    Ann Surg Oncol; 2018 Oct; 25(10):3030-3036. PubMed ID: 29978371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node biopsy in early breast carcinoma using fluorescein sodium and methylene blue dye: A validation study.
    Jha CK; Sinha U; Singh PK; Parasar K; Kumar M
    Trop Doct; 2024 Oct; 54(4):340-345. PubMed ID: 39043045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node biopsy using dye alone method is reliable and accurate even after neo-adjuvant chemotherapy in locally advanced breast cancer--a prospective study.
    Chintamani ; Tandon M; Mishra A; Agarwal U; Saxena S
    World J Surg Oncol; 2011 Feb; 9():19. PubMed ID: 21396137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy and Limitations of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients with Positive Nodes.
    Aragon-Sanchez S; Oliver-Perez MR; Madariaga A; Tabuenca MJ; Martinez M; Galindo A; Arroyo ML; Gallego M; Blanco M; Ciruelos-Gil EM
    Breast J; 2022; 2022():1507881. PubMed ID: 36051467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patient.
    Franceschini G; Di Leone A; Sanchez AM; D'Archi S; Terribile D; Magno S; Scardina L; Masetti R
    Ann Ital Chir; 2020; 91():465-468. PubMed ID: 32312945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can Low-cost Indo Cyanine Green Florescence Technique for Sentinel Lymph Node Biopsy Replace Dual Dye (Radio-colloid and Blue Dye) Technique in Early Breast Cancer: A Prospective Two-arm Comparative Study.
    Somashekhar SP; Kumar CR; Ashwin KR; Zaveri SS; Jampani A; Ramya Y; Parameswaran R; Rakshit S
    Clin Breast Cancer; 2020 Oct; 20(5):e576-e583. PubMed ID: 32389561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node BIOPSY after neoadjuvant therapy in breast cancer patients with lymph node involvement at diagnosis. Could wire localization of clipped node improve our results?
    Alarcón M; Buch E; Julve A; Hernandorena M; Tajahuerce M; Rodríguez H; Bermejo B; Ramírez J; Burgués O; Díaz S; Alcalá GM; Ortega J
    Surgeon; 2021 Dec; 19(6):344-350. PubMed ID: 33663946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.
    Diego EJ; McAuliffe PF; Soran A; McGuire KP; Johnson RR; Bonaventura M; Ahrendt GM
    Ann Surg Oncol; 2016 May; 23(5):1549-53. PubMed ID: 26727919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer.
    DeSnyder SM; Mittendorf EA; Le-Petross C; Krishnamurthy S; Whitman GJ; Ueno NT; Woodward WA; Kuerer HM; Akay CL; Babiera GV; Yang W; Lucci A
    Clin Breast Cancer; 2018 Feb; 18(1):e73-e77. PubMed ID: 28755879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.